[DOI] [PubMed] [Google Scholar] Gavrilova S.I., Kalyn Y.B., Kolykhalov I.V., Roshchina I.F., Selezneva N.D
Multi-System Reach Beyond the gut, BPC-157 has preclinical evidence across tendons, ligaments, muscles, bone, the liver, and the nervous system
Localized effect: Because it has a short half-life (about 2030 minutes), it is most effective when applied directly to the target area, such as a muscle group that needs growth or recovery
doi: 10.1016/0306-4522(93)90175-f 67
Rexulti is also indicated for the treatment of schizophrenia in patients ages 13 years and older, and for the treatment of agitation associated with dementia resulting from Alzheimers disease
The FDA emphasizes that many compounded semaglutide products may use salt forms (such as semaglutide sodium or acetate), which differ from the active ingredients in approved formulations and lack evidence of safety or efficacy